Zach Lomis – Startup Investor Profile

Zach Lomis, a Partner at Palo Santo VC in New York, is actively involved in the healthcare sector, particularly focusing on Therapeutics (Seed), (Series A), and (Series B) investments. His recent investments include Seed Therapeutics. With a current fund size of $50M, Zach Lomis typically invests in the range of $100K to $5.0M, with a sweet spot of $1.5M. Throughout his career, he has held roles such as Director of Biz Ops at Heading Health, Founder at Stealth Mode, and Venture Partner at Oncology Ventures. Zach’s academic background includes a Bachelor of Science in Finance from Washington University in St. Louis. He values collaboration and partnership in his professional endeavors, seeking to create successful synergies in the healthcare industry.

Location:

Country: United States of America

Investment Regions: EU, NA

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Found evidence of Zach Lomis as Partner at Palo Santo with portfolio investments including Reset Pharma, Delix, Gilgamesh, Ksana Health, Bexson Biomedical, Journey Clinical and others; press release dated Feb 2, 2022. Also LinkedIn activity in Oct 2022 mentioning fund close and investments (noting Seed Therapeutics referenced in user data). I could not find any investment announcements by Zach Lomis after Oct 2022 or during 2023-2025. The most recent verifiable activity is Oct 2022 (Seed/Giac related portfolio mentions) which is 3 years and ~1 month prior to the reference date; however the user-stated data mentions a recent investment in Seed Therapeutics – but I could not find a public dated deal more recent than Oct 2022. Given the absence of any verifiable investments within the last 12 months but evidence of activity between 12 and 36 months, classification is “active”.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.